How Marta Bralic Kerns Built a $1.7 Billion Femtech Unicorn From a Mother’s Experience

Why It Matters

Pomelo Care proves that data‑driven, preventive femtech can improve maternal outcomes while lowering insurer and employer expenses, reshaping a traditionally reactive segment of healthcare.

Key Takeaways

• Pomelo Care valued at $1.7 B after $92 M Series C
• Covers 25 M lives, serving ~7% of U.S. births
• Demonstrated cuts in preterm births and NICU use
• Partners with insurers, employers like Koch for cost savings
• Expanding into reproductive health, pediatrics, menopause markets

Pulse Analysis

The rise of Pomelo Care reflects a broader shift toward femtech solutions that marry technology with preventive medicine. While digital health has proliferated across chronic disease management, women’s health remained under‑invested despite representing a sizable economic burden. Bralic Kerns leveraged her consulting background and personal maternity challenges to create a platform that aggregates real‑time data, predictive analytics, and multidisciplinary clinical teams, delivering continuous virtual support that traditional obstetric care cannot match. This model not only fills a glaring gap in patient experience but also aligns with insurers’ and employers’ appetite for cost‑containment.

Pomelo’s business model hinges on measurable clinical outcomes rather than mere engagement metrics. Peer‑reviewed studies, conducted with the Leonard Davis Institute, show statistically significant reductions in preterm births, NICU admissions, and emergency‑room visits, translating into tangible savings for health plans. The $92 million Series C injection, led by Stripes and backed by Andreessen Horowitz and others, underscores investor belief that scalable, outcome‑based virtual care can dominate a $1‑trillion femtech opportunity projected for 2040. Strategic partnerships with major payers and corporations such as Koch further validate the platform’s value proposition, offering employers a tool to curb one of the costliest categories in employee health benefits.

Looking ahead, Pomelo Care’s expansion beyond maternity into reproductive health, pediatrics, and menopause positions it as a lifelong women’s‑health ecosystem. By adhering to regulatory standards and maintaining rigorous clinical governance, the company builds credibility essential for broader adoption. As telemedicine matures, the firm’s emphasis on prevention, personalization, and data‑driven accountability could set a new benchmark for digital health, encouraging other innovators to prioritize outcomes that matter to both patients and the bottom line.